Nalu Medical
Mr. Tutera has served as the Vice President of Market Access since November 2022. Prior to joining Nalu, Mr. Tutera served from 2019 to 2022 as Global Vice President, Market Access and Reimbursement, at Intersect ENT, Inc., a publicly-traded medical device and drug delivery company. Intersect was acquired by Medtronic in May of 2022. Prior to Intersect, Mr. Tutera served as US Head of Market Access at Mallinckrodt Pharmaceuticals from 2015 to 2019. Mr. Tutera began his healthcare career at Forest Laboratories, now AbbVie, where he assumed roles of increasing responsibility over a 15 year tenure including US Area Director of Market Access, Director of Market Access Training and Leadership Development, and various roles in Sales and Sales Leadership.
Mr. Tutera received a B.A. in Economics from the University of Pittsburgh.
This person is not in any teams
This person is not in any offices
Nalu Medical
Nalu Medical, Inc. is a privately held commercial medical device company based in Carlsbad, California. The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The system is highly capable and easily upgradeable, providing a menu of therapy options.